Hanmi launches Nexium competitor in the US
This article was originally published in Scrip
Executive Summary
AstraZeneca's blockbuster PPI Nexium (esomeprazole magnesium) has a new competitor in the US market in the form of an esomeprazole strontium product sold by Hanmi Pharmaceutical and its US marketing partner Amneal Pharmaceuticals.